Howe & Rusling’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Howe & Rusling’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11	Closed	-$1K	–	1121
2016 Q1	$1K	Buy	11 +3	+38%	+$221	﹤0.01%	995
2015 Q4	$1K	Buy	8 +4	+100%	+$441	﹤0.01%	981
2015 Q3	$0	Buy	+4	New	+$522	﹤0.01%	1135

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Howe & Rusling's ANAC Position: Q2 2016 in Review

Howe & Rusling sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 11 shares — an estimated $1K sold.

Howe & Rusling first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $1K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Howe & Rusling reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Howe & Rusling sold 11 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1K.
Howe & Rusling first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Howe & Rusling's ANACOR PHARMACEUTICALS INC COM position peaked at $1K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Howe & Rusling's 13F filing for Q2 2016, filed 23 Aug 2016.